Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - glycopyrronium bromide - solution for injection - 200microgram/1ml

Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

colonis pharma ltd - glycopyrronium bromide - oral solution - 200microgram/1ml

Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

martindale pharmaceuticals ltd - glycopyrronium bromide - solution for injection - 200 microgram(s)/millilitre - synthetic anticholinergics, quaternary ammonium compounds; glycopyrronium bromide

Malta - Kiingereza - Malta Medicines Authority

colonis pharma limited quantum house, hobson industrial estate, burnopfield, country, durham ne16 6ea, united kingdom - glycopyrronium bromide - oral solution - glycopyrronium bromide 1 mg/5ml - drugs for functional gastrointestinal disorders

Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - glycopyrronium bromide - oral tablet - 1mg

Umoja wa Ulaya - Kiingereza - EMA (European Medicines Agency)

chanelle pharmaceuticals manufacturing ltd - selamectin - antiparasitic products, insecticides and repellents - cats; dogs - cats and dogs:treatment and prevention of flea infestations caused by ctenocephalides spp. for one month following a single administration. this is as a result of the adulticidal, larvicidal and ovicidal properties of the product. the product is ovicidal for 3 weeks after administration. through a reduction in the flea population, monthly treatment of pregnant and lactating animals will also aid in the prevention of flea infestations in the litter up to seven weeks of age. the product can be used as part of a treatment strategy for flea allergy dermatitis and through its ovicidal and larvicidal action may aid in the control of existing environmental flea infestations in areas to which the animal has access.prevention of heartworm disease caused by dirofilaria immitis with monthly administration.the product may be safely administered to animals infected with adult heartworms, however, it is recommended, in accordance with good veterinary practice, that all animals 6 months of age or more living in countries where a vector exists should be tested for existing adult heartworm infections before beginning medication with the product. it is also recommended that dogs should be tested periodically for adult heartworm infections, as an integral part of a heartworm prevention strategy, even when the product has been administered monthly. this product is not effective against adult d. immitis.treatment of ear mites (otodectes cynotis).cats:treatment of biting lice infestations (felicola subrostratus)treatment of adult roundworms (toxocara cati)treatment of adult intestinal hookworms (ancylostoma tubaeforme)treatment of biting lice infestations (trichodectes canis)treatment of sarcoptic mange (caused by sarcoptes scabiei)

Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

p.i.e. pharma ltd - glycopyrronium bromide - oral tablet - 1mg

Umoja wa Ulaya - Kiingereza - EMA (European Medicines Agency)

virbac s.a. - selamectin - endectocides - cats; dogs - treatment and prevention of flea infestations caused by ctenocephalides spp. for one month following a single administration. this is as a result of the adulticidal, larvicidal and ovicidal properties of the product. the product is ovicidal for 3 weeks after administration. through a reduction in the flea population, monthly treatment of pregnant and lactating animals will also aid in the prevention of flea infestations in the litter up to seven week of age. the product can be used as part of a treatment strategy for flea allergy dermatitis and through its ovicidal and larvicidal action may aid in the control of existing environmental flea infestations in area to which the animal has access.prevention of heartworm disease caused by dirofilaria immitis with monthly administration. the product may be safely administered to animals infected with adult heartworms, however, it is recommended, in accordance with good veterinary practice, that all animals 6 months of age or more living in countries where a vector exists should be tested for existing adult heartworm infections before beginning medication with the product. it is also recommended that dogs should be tested periodically for adult heartworm infections, as an integral part of a heartworm prevention strategy, even when the product has been administered monthly. this product is not effective against adult d. immitis.treatment of ear mites (otodectes cynotis).cats:treatment of biting lice infestations (felicola subrostratus)treatment of adult roundworms (toxocara cati)treatment of adult intestinal hookworms (ancylostoma tubaeforme).dogs:treatment of biting lice infestations (trichodectes canis)treatment of sarcoptic mange (caused by sarcoptes scabiei)treatment of adult intestinal roundworms (toxocara canis).

Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - glycopyrronium bromide - oral tablet - 1mg

Umoja wa Ulaya - Kiingereza - EMA (European Medicines Agency)

elanco gmbh - tulathromycin - antibacterials for systemic use - cattle; pigs; sheep - cattle: treatment and metaphylaxis of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni and mycoplasma bovis susceptible to tulathromycin. the presence of the disease in the herd should be established before metaphylactic treatment.treatment of infectious bovine keratoconjunctivitis (ibk) associated with moraxella bovis susceptible to tulathromycin.pigs: treatment and metaphylaxis of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, mycoplasma hyopneumoniae, haemophilus parasuis and bordetella bronchiseptica susceptible to tulathromycin. the presence of the disease in the herd should be established before metaphylactic treatment. the product should only be used if pigs are expected to develop the disease within 2–3 days.sheep: treatment of the early stages of infectious pododermatitis (foot rot) associated with virulent dichelobacter nodosus requiring systemic treatment.